How many insider trades does FilingIQ track for RGNT?

FilingIQ tracks 8 Form 4 insider transactions for RGNT (REGENTIS BIOMATERIALS LTD.), covering filings from Jul 9, 2026 onwards. 8 of those were filed in the last 90 days.

Are RGNT insiders net buyers or net sellers?

Across the full Form 4 history for RGNT, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does RGNT insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is RGNT in?

REGENTIS BIOMATERIALS LTD. (RGNT) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $24.37M.

RGNT insider trading

NYSE American Healthcare

REGENTIS BIOMATERIALS LTD. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

0% / 0%

Market cap

$24.37M

About REGENTIS BIOMATERIALS LTD.

Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, Israel.

Company website: www.regentis.co.il

RGNT insider activity at a glance

FilingIQ has scored 8 insider transactions for RGNT since Jul 9, 2026. The most recent filing in our index is dated Jul 9, 2026.

Across the full history, 0 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

View live RGNT trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,070

UNITED THERAPEUTICS Corp

APLS 272

Apellis Pharmaceuticals, Inc.

NUVL 218

Nuvalent, Inc.

KYMR 215

Kymera Therapeutics, Inc.

HNGE 194

Hinge Health, Inc.

GH 189

Guardant Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for RGNT?: FilingIQ tracks 8 Form 4 insider transactions for RGNT (REGENTIS BIOMATERIALS LTD.), covering filings from Jul 9, 2026 onwards. 8 of those were filed in the last 90 days.
Are RGNT insiders net buyers or net sellers?: Across the full Form 4 history for RGNT, 0 transactions (0%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does RGNT insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is RGNT in?: REGENTIS BIOMATERIALS LTD. (RGNT) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $24.37M.

Methodology & sources

Every RGNT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.